Page last updated: 2024-08-22

cladribine and Allergic Encephalomyelitis

cladribine has been researched along with Allergic Encephalomyelitis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Bock, S; Budde, T; Cerina, M; Dobelmann, V; Duarte-Silva, E; Fazio, L; Gothan, KSS; Gruchot, J; Henes, A; Herrmann, AM; Hundehege, P; Huntemann, N; Kremer, D; Küry, P; Meuth, SG; Müntefering, T; Narayanan, V; Nelke, C; Pfeuffer, S; Raba, K; Räuber, S; Rolfes, L; Ruck, T; Schroeter, CB; Wiendl, H1
Centonze, D; Fresegna, D; Gentile, A; Haji, N; Mandolesi, G; Matarese, G; Motta, C; Musella, A; Paolillo, A; Rossi, S; Sepman, H; Studer, V1
Fontoura, P; Garren, H1

Reviews

1 review(s) available for cladribine and Allergic Encephalomyelitis

ArticleYear
Multiple sclerosis therapies: molecular mechanisms and future.
    Results and problems in cell differentiation, 2010, Volume: 51

    Topics: Alemtuzumab; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Cladribine; Crotonates; Daclizumab; Dimethyl Fumarate; Encephalomyelitis, Autoimmune, Experimental; Fingolimod Hydrochloride; Fumarates; Humans; Hydroxybutyrates; Immunoglobulin G; Immunosuppressive Agents; Immunotherapy; Mice; Multiple Sclerosis; Myelin Basic Protein; Nitriles; Peptide Fragments; Propylene Glycols; Quinolones; Rituximab; Sphingosine; Toluidines; Vaccines, DNA

2010

Other Studies

2 other study(ies) available for cladribine and Allergic Encephalomyelitis

ArticleYear
Cladribine treatment improves cortical network functionality in a mouse model of autoimmune encephalomyelitis.
    Journal of neuroinflammation, 2022, Nov-08, Volume: 19, Issue:1

    Topics: Animals; Cladribine; Disease Models, Animal; Encephalomyelitis; Encephalomyelitis, Autoimmune, Experimental; Immunosuppressive Agents; Mice; Mice, Inbred C57BL; Neuroprotective Agents

2022
Cladribine interferes with IL-1β synaptic effects in experimental multiple sclerosis.
    Journal of neuroimmunology, 2013, Nov-15, Volume: 264, Issue:1-2

    Topics: Animals; Cell Proliferation; Cerebral Cortex; Chelating Agents; Cladribine; Corpus Striatum; Disease Models, Animal; Drug Delivery Systems; Egtazic Acid; Encephalomyelitis, Autoimmune, Experimental; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Female; Glial Fibrillary Acidic Protein; Glutamic Acid; Immunosuppressive Agents; In Vitro Techniques; Interleukin-1beta; Mice; Mice, Inbred C57BL; Neuroglia; Patch-Clamp Techniques; Synapses

2013